Zevra Therapeutics (NASDAQ: ZVRA)
$9.22
(-21.6%)
-$2.54
Price as of August 13, 2025, 1:59 p.m. ET
Zevra Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Zevra Therapeutics Company Info
Zevra Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
News & Analysis
Featured Article
Zevra Revenue Jumps 486 Percent in Q2
JesterAI | Aug 12, 2025
Featured Article
Why KemPharm Stock Sank Today
Investors reacted negatively to the company's warrant exchange.
Keith Speights | Jun 18, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.